These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 4985374

  • 1. [Cytostatic effect of L-asparaginase].
    Rakowska-Wódz A, Szyszka K, Abucewicz A.
    Wiad Lek; 1970 Jan 15; 23(2):117-20. PubMed ID: 4985374
    [No Abstract] [Full Text] [Related]

  • 2. [L-asparaginase--first specific cytostatic].
    Marquardt H.
    Arzneimittelforschung; 1968 Nov 15; 18(11):1380-6. PubMed ID: 4885156
    [No Abstract] [Full Text] [Related]

  • 3. [Enzyme therapy of malignant tumors].
    Jacobasch KH.
    Arch Geschwulstforsch; 1969 Nov 15; 34(4):364-75. PubMed ID: 4920119
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Antineoplastic activity of L-asparaginase].
    Grgić Z.
    Lijec Vjesn; 1969 Jul 15; 91(7):783-6. PubMed ID: 4910066
    [No Abstract] [Full Text] [Related]

  • 7. Biochemical method of cancer control. L-asparaginase in cancer chemotherapy. A review.
    Jayaram HN, Sirsi M.
    Indian J Cancer; 1970 Mar 15; 7(1):71-7. PubMed ID: 4992298
    [No Abstract] [Full Text] [Related]

  • 8. A review of the preclinical antitumor activity and toxicology of L-asparaginase derived from E. coli.
    Charles LM, Bono VH.
    Cancer Treat Rep; 1981 Mar 15; 65 Suppl 4():39-46. PubMed ID: 7049380
    [No Abstract] [Full Text] [Related]

  • 9. L-Asparaginase: discovery and development as a tumor-inhibitory agent.
    Broome JD.
    Cancer Treat Rep; 1981 Mar 15; 65 Suppl 4():111-4. PubMed ID: 7049374
    [No Abstract] [Full Text] [Related]

  • 10. [Clinical significance of L-asparaginase].
    Benkö S.
    Orv Hetil; 1969 Aug 31; 110(35):2019-23. PubMed ID: 4900161
    [No Abstract] [Full Text] [Related]

  • 11. [The antitumor activity of L-asparaginase].
    Adamson RH, Fabro S.
    Acta Vitaminol Enzymol; 1969 Aug 31; 23(3):111-24. PubMed ID: 4897937
    [No Abstract] [Full Text] [Related]

  • 12. Immunosuppressive action of L-asparaginase.
    Alexander P.
    Proc R Soc Med; 1972 Mar 31; 65(3):265-6. PubMed ID: 5083314
    [No Abstract] [Full Text] [Related]

  • 13. [A new antineoplastic drug: the L-asparaginase. Future possibilities of antitumor enzymotherapy].
    Nervi C, Casale C, Cortese M.
    Policlinico Prat; 1969 Mar 10; 76(10):297-304. PubMed ID: 5252042
    [No Abstract] [Full Text] [Related]

  • 14. In vitro test for sensitivity of leukemic cells to L-asparaginase.
    Schrek R, Dolowy WC.
    Cancer Res; 1971 May 10; 31(5):523-6. PubMed ID: 4932205
    [No Abstract] [Full Text] [Related]

  • 15. [Lymphocytes after cytostatic therapy with L-asparaginase. Transformation rate, mitotic index and chromosomes].
    Vormittag W, Pietschmann H.
    Wien Klin Wochenschr; 1972 Jan 28; 84(4):64-7. PubMed ID: 5012929
    [No Abstract] [Full Text] [Related]

  • 16. [L-asparaginase, a new drug of antileukemic action].
    Hernádi F.
    Orv Hetil; 1969 Jan 26; 110(4):187-9. PubMed ID: 5779083
    [No Abstract] [Full Text] [Related]

  • 17. [The use of asparaginase preparations for the treatment of tumors and leukemia (review of the literature)].
    Nikolaev AIa.
    Probl Gematol Pereliv Krovi; 1969 Jul 26; 14(7):51-60. PubMed ID: 4903458
    [No Abstract] [Full Text] [Related]

  • 18. Antitumor activity and other biologic properties of L-asparaginase (NSC-109229)-a review.
    Adamson RH, Fabro S.
    Cancer Chemother Rep; 1968 Oct 26; 52(6):617-26. PubMed ID: 4895425
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. In-vitro cytotoxicity of L-asparaginase on rodent and human neoplastic cells.
    Schrek R, Dolowy WC.
    Lancet; 1970 Oct 03; 2(7675):722. PubMed ID: 4195957
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.